Betamethasone valerate (topical)
بتامتازون والرات موضعی
🧴 DermatologicalsPotent topical corticosteroid
Market / country: 🇺🇸 USA
Betnovate (GB)
🧮 Dose calculator
Dermatitis and itchy skin rash · Regimen source: FDA Betamethasone val. · Dosage and Administration
- • Morning and night; once daily after improvement. FDA Betamethasone val. · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to any component. FDA Betamethasone val. · Contraindications
Warnings
- • Children are more susceptible to HPA-axis suppression and Cushing's syndrome from topical steroids; use the least effective amount. FDA Betamethasone val. · Pediatric Use
Formulations
- 0.1% ointment — ointment 🇺🇸 USA FDA Betamethasone val. · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Darooyab: category C — only if benefit outweighs risk. Darooyab · G-4563/Betamethasone-Topical — مصرف در بارداری
“مصرف در بارداری بتامتازون موضعی گروه C در شرايط خاص و نظارت ويژه پزشك قابل استفاده است:”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Betamethasone val. · Precautions/Warnings – Nursing Mothers
“Nevertheless, caution should be exercised when topical corticosteroids are administered to a nursing woman.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Betamethasone val. · Precautions/Warnings – Pediatric Use
“Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA018865
- DailyMed (FDA label)FDA Betamethasone val.
- MedlinePlus (NIH)Betamethasone Topical
- WHO ATC/DDDD07AC01
- Darooyab (Iran)Betamethasone-Topical
🇮🇷 Registered in Iran Darooyab · G-4563/Betamethasone-Topical
Dosage forms with Iranian generic codes, per Darooyab.
- 05476 · BETAMETHASONE 0.1% 100G OINT · پماد بتامتازون ۰٫۱ درصد ۱۰۰ گرم
- 00161 · BETAMETHASONE 0.1% 15G CREAM · کرم بتامتازون ۰٫۱ درصد ۱۵ گرم
- 00160 · BETAMETHASONE 0.1% 15G OINT · پماد بتامتازون ۰٫۱ درصد ۱۵ گرم
- 00159 · BETAMETHASONE 0.1% LOTION · لوسیون بتامتازون ۰٫۱ درصد
- 51913 · BETAMETHASONE (AS VALERATE) OINTMENT TOPICAL 0.1 % 500 g · پماد بتامتازون (معادل والرات) ۰٫۱ درصد ۵۰۰ گرم
- 52657 · BETAMETHASONE (AS VALERATE) CREAM TOPICAL 0.1 % 100 g · کرم بتامتازون (معادل والرات) ۰٫۱ درصد ۱۰۰ گرم
- 52659 · BETAMETHASONE (AS VALERATE) OINTMENT TOPICAL 0.1 % 100 g · پماد بتامتازون (معادل والرات) ۰٫۱ درصد ۱۰۰ گرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Betamethasone val. · How SuppliedFDA Betamethasone val. · Dosage and AdministrationFDA Betamethasone val. · ContraindicationsFDA Betamethasone val. · Pediatric UseFDA Betamethasone val. · Precautions/Warnings – Nursing MothersFDA Betamethasone val. · Precautions/Warnings – Pediatric UseFDA Betamethasone val. · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-4563/Betamethasone-TopicalDarooyab · G-4563/Betamethasone-Topical — مصرف در بارداری
- Clinical review⚠ Unverified